DOCSLIB.ORG

MICHELE T ROONEY, MD BOARD CERTIFICATIONS RENAL PATHOLOGY • Anatomic & Clinical Pathology • Cytopathology Dr

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
MICHELE T ROONEY, MD BOARD CERTIFICATIONS RENAL PATHOLOGY • Anatomic & Clinical Pathology • Cytopathology Dr MICHELE T ROONEY, MD BOARD CERTIFICATIONS RENAL PATHOLOGY • Anatomic & Clinical Pathology • Cytopathology Dr. Rooney is a highly experienced surgical and medical specialties, which FELLOWSHIP pathologist, board certified in anatomic required generalist as well as a high level • Surgical Pathology, Mayo Graduate and clinical pathology, cytopathology, and of subspecialty expertise. School of Medicine, Rochester, MN fellowship trained in renal pathology. During her time at William Beaumont, RESIDENCIES • Surgical Pathology, Mayo Graduate Dr. Rooney received her medical degree Dr. Rooney was well respected by her School of Medicine, Rochester, MN from the University of Minnesota Medical peers and became the go-to person for a • Anatomic & Clinical Pathology, SUNY School in Minneapolis, MN. While there number of subspecialties within surgical Upstate Medical University, Syracuse, she completed a post-sophomore fellowship pathology. She gained experience in NY in pathology. a high volume hospital laboratory with state of the art facilities in molecular and MEDICAL/DOCTORATE DEGREE She completed her first three years of cytogenetic testing. In addition, Dr. Rooney • University of Minnesota Medical primary pathology residency training in School, Minneapolis, MN served as Director of Residency Training anatomic and clinical pathology at SUNY in Pathology, Associate Professor at the Upstate Medical University in Syracuse, HOSPITAL AFFILIATIONS Oakland University William Beaumont • Holy Family Hospital NY and her fourth and fifth years at the School of Medicine, and was a member of • Kootenai Medical Center Mayo Graduate School of Medicine in the Pathologist’s Board at William Beaumont • Sacred Heart Medical Center Rochester, MN. Her fifth year included a • Valley Hospital & Medical Center Hospital, representing the largest anatomic CAP-sponsored fellowship for molecular pathology division. PROFESSIONAL SOCIETIES & research. Upon completion of her residency, ASSOCIATIONS she remained at the Mayo Graduate School At Beaumont Hospitals she trained on • College of American Pathologists of Medicine to complete her fellowship the job in kidney pathology and became • United States and Canadian Academy training in surgical pathology. part of the kidney pathology service. She of Pathology subsequently sought formal fellowship Following residency training, Dr. Rooney training in kidney pathology at Nephropath returned to SUNY Upstate Medical Center. Diagnostics, and she completed a For the first six months there, she functioned fellowship there, modified for her advanced as a cytopathology fellow, enabling her experience, in March of 2015. to sit for the certifying examination in cytopathology with experience. In addition, Dr. Rooney is a member of the College of she served as staff pathologist and assistant American Pathologists, a former member of professor of the SUNY Upstate School of the Tumor Marker Committee of the College Medicine. She also served as Assistant of American Pathologists, a member of the Director of Surgical Pathology, and she was United States and Canadian Academy of recognized in one year by the residents as Pathology, the Renal Pathology Society, and Best Teacher in Pathology. the American Society of Nephrology. Four years later, Dr. Rooney became an attending pathologist in the Department of Anatomic Pathology at the William Beaumont Hospital (a 1,200 bed teaching hospital) in Royal Oak, MI. William Beaumont Hospital laboratories process a high volume of specimens from multiple MICHELE T ROONEY, MD RENAL PATHOLOGY PRESENTATIONS the College of American Pathologists, • Desai, H., Parasuraman, R., • “Electron Microscopic (EM) Identification Orlando, FL. October 2013. Samarpungavan, D., Rooney, M., & et al of Myeloid Bodies in Proximal Tubules (2011). Glomerulitis during acute cellular • “Immunohistochemical Validation of IgG4 Due to Aminoglycoside Toxicity - Old rejection may be a surrogate marker of Staining in Glomeruli in a Large Range of Finding and New Application, Case vasculitis in renal allografts: Better index Renal Biopsies”. Annual Meeting of the Report”. Annual Meeting of the College for diagnosis of vasculitis. Transplantation American Society of Nephrology, Atlanta, of American Pathologists, Chicago, IL. Proceedings, (43) 1629-1633. GA. November 2013. September 2014. • Wiesend, W., Parasuraman, R., Li, W., • “Stem/progenitor cell marker CD133 • “Natural Killer Cells Are Involved in both Farinola, M., Rooney, M., & et al (2010). identifies glomerular and tubular injury in Acute Antibody Mediated Rejection and Adjuvant role of p53 immunostaining human renal biopsies”. United States and Acute Cellular Rejection”. Annual Meeting in detecting BK viral infection in renal Canadian Academy of Pathology Annual of the College of American Pathologists, allograft biopsies. Annals of Clinical & Meeting, Vancouver, BC. March 2012. Chicago, IL. September 2014. Laboratory Science, (4) 324-329. • “Upregulated mTOR pathway in primary • “Combined Erdheim Chester Disease • Hong, S., Shirkhoda, A., Rooney, M., & crescentic glomerulonephritis”. United (ECD) and Langerhans Cell Histiocytosis et al (2008). Burkitt Lymphoma: Spectrum States and Canadian Academy of (LCH) with BRAF V600E Mutation”. of Imaging Findings. Contemporary Pathology, Vancouver, BC. March 2012. Annual Meeting of the College of Diagnostic Radiology (23) 1-6. American Pathologists, Chicago, IL. • “Cilia metaplasia in renal transplant • Wilson, J., Wang, A., Zakalik, K. September 2014. biopsies with acute tubular injury”. & Rooney M. (2006). Recurrent United States and Canadian Academy • “Denervated Renal Graft Explants Have Hemangiopericytoma with keloidal of Pathology 100th Annual Meeting, San Extensive Damage of the Juxtaglomerular collagen versus cellular solitary fibrous Antonio, TX, February 2011. Apparatus and Neural Network”. tumor. Brain Pathology, (234) S1117. United States and Canadian Academy • “Immunofluorescent slides for renal • Elia, G., Perez-Reyes, N., Rooney, M., of Pathology Annual Meeting. March biopsies can be safely used for review Dye, T. (2003). Evaluation of the estrogen 2013. after one and half years of storage in status of the lower urinary tract in women: room temperature”. United States and • “Injured Proximal Tubular Epithelium Can a prospective study. The Journal of the Canadian Academy of Pathology 100th Differentiate into Vimentin Positive Cells American Osteopathic Association, (103) Annual Meeting, San Antonio, TX, in Human Kidneys”. United States and 8. February 2011. Canadian Academy of Pathology Annual • Gajra, A., Tatum, A., Newman, N., Meeting. March 2013. • “Immunohistochemical stains of kappa Camble, G., Lichtenstein, S., Rooney, and lambda confirm monoclonality by • “Sequential comparison between M., & et al (2002). The predictive value immunofluorescent studies and reveal mesonephros and metanephros at 7 of neuroendocrine markers and p53 for a highpercent of “hybrid” proximal weeks gestation - case report”. Annual response to chemotherapy and survival in tubulopathy in light chains associated Meeting of the College of American patients with advanced non-small cell lung monoclonal nephropathy”. United States Pathologists, Orlando, FL. October 2013. cancer. Lung Cancer, (36) 159-65. and Canadian Academy of Pathology • “Concurrent Renal Sarcoidosis and Renal (USCAP) 100th Annual Meeting, San • Garcia, D., Rooney, M., & et al (2001). cell Carcinoma in a Young Man”. Annual Antonio, TX, February 2011. Diagnostic usefulness of CD23 and FMC- Meeting of the College of American 7 antigen expression patterns in B-cell PUBLICATIONS Pathologists, Orlando, FL. October 2013. lymphoma classification. American Journal • Parasuraman, R., Wolforth, S., Wiesend, of Clinical Pathology, (115) 258-65. • “Concurrent Renal-Limited Plasmacytoma- W., Dumler, F,. Rooney, M., & et al Like Post-Transplant Lymphoproliferative (2013). Contribution of Polyclonal Free Disorder (PL-PTLD) and Metastatic Breast Light Chain Deposition to Tubular Injury. Carcinoma in a Renal Transplant Recipient American Journal of Nephrology, (38), - A Case Report”. Annual Meeting of 465-474. Rev 4/2015 ID000194 13103 E. Mansfield Avenue 509.892.2700 OFFICE Spokane Valley, WA 99216-1642 888.814.6277 TOLL FREE 509.892.2740 FAX incytediagnostics.com.
Load more

Recommended publications
  • Resident Handout
    Resident Handout Division of Transplantation Pathology University of Pittsburgh Medical Center July 2005 for private use of residents only- not for public distribution Table of Contents Anatomic Transplantation Pathology Rotation Clinical Responsibilities of the Division ........................................................4 Categorizations of Specimens and Structure of Signout.............................…4 Resident Responsibilities.................................................................................5 Learning Resources.........................................................................................6 Transplantation Pathology on the World-Wide Web......................................6 Weekly Schedule ............................................................................................7 Staff Locations and Telephone Numbers........................................................8 Background Articles Landmarks in Transplantation ...................…..................................................9 History of Transplant Immunobiology Part 1....…..........................................19 History of Transplant Immunobiology Part 2....…..........................................25 Kidney Grading Systems Banff 97 Diagnostic Grades (IA, IB etc.) .............................….....................33 Banff 97 Components (I t v g etc.) ....................................…........................35 Readings Banff 97 Working Classification of Renal Allograft Pathology….................38 Role of Donor Kidney Biopsies
    [Show full text]
  • Practice Guidelines for the Renal Biopsy
    Modern Pathology (2004) 17, 1555–1563 & 2004 USCAP, Inc All rights reserved 0893-3952/04 $30.00 www.modernpathology.org Practice guidelines for the renal biopsy Patrick D Walker1, Tito Cavallo2, Stephen M Bonsib3, The Ad Hoc Committee on Renal Biopsy Guidelines of the Renal Pathology Society 1Nephropathology Associates, Little Rock, AR, USA; 2Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati OH, USA and 3Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA Biopsy of the kidney should never be undertaken without careful consideration of the risks vs benefits. Given the importance of a correct diagnosis in the treatment and prognosis of renal disease, the pathological evaluation should use all available modalities. Native kidney biopsies require examination by light microscopy, immunohistochemistry and electron microscopy. The processing of the renal biopsy is complex and requires the support of a fully equipped anatomic pathology laboratory. Technical expertise is required to process the small fragments of tissue and to produce sections of highest quality. The correct diagnosis requires a well- trained renal pathologist with thorough knowledge of not only renal pathology but also renal medicine in order to correlate intricate tissue-derived information with detailed clinical data. In view of the importance and consequences of the pathologic diagnosis, the Renal Pathology Society appointed an Ad Hoc Committee on Practice Guidelines, to define the essential ingredients necessary to provide quality renal pathology diagnoses. This document incorporates the consensus opinions of the committee and the RPS membership at large. Modern Pathology (2004) 17, 1555–1563, advance online publication, 23 July 2004; doi:10.1038/modpathol.3800239 Keywords: renal biopsy; glomerulonephritis; allograft; transplant rejection The renal biopsy, though a relatively safe medical refinement.
    [Show full text]
  • A Closer Look at the Division of Genitourinary Pathology
    PathWays NEWS AND INFORMATION FROM JOHNS HOPKINS PATHOLOGY December A Closer Look at the Division of Genitourinary Pathology Clockwise from L-R: Yuly Ramirez, Jonathan Epstein, Zhiming Yang, Oudai Hassan; Aline Tregnago, Jennifer Collins, Alex Baras, Jessica Forcucci, Walaa Borhan 6 9 14 21 Retirements The Obama - Celebrating New Baxley Hopkins Pathology Inside Connection History iPad Video Project Apps DIRECTOR’S CORNER The Phoenix I grew up in the shadows of the University of Chicago their unique talents to move the and quickly learned about the school’s mascot—the phoenix. Department forward. The phoenix (φοῖνιξ) is a mythological bird that is cyclically Finally, with the retirement of reborn. A new phoenix rises from the fiery ashes of its Rosemary Hines, Chris Ruley is our predecessor, even more beautiful and magnificent than before new finance director. Chris is also the (see Joseph Nigg’s book, The Phoenix: An Unnatural Biography finance director for Radiology and of a Mythical Beast). Just as the phoenix is reborn, so are Pharmacy. departments periodically “reborn” with changes in leadership, The impact of all of this change faculty and staff. Indeed, 2016 has been a beautiful year of is palpable. Total sponsored research renewal for our Department of Pathology! (direct and indirect) increased by As you will read about on page 8, this year we welcomed 18% from FY15 to FY16 (page 20). nine new faculty and a clinical associate. These talented young Since January 1, new or competitive people include Eric Gehrie in Transfusion Medicine, “Bear” R01 grants have been awarded to Huang in Gynecologic Pathology, Aaron James in Bone Mario Caturegli, Tamara Lotan, Charles Ralph H.
    [Show full text]
  • Section 11 – Program Objectives for Surgical Pathology Fellowship
    Section 11: Program Objectives, Goals, and Supervision of Fellows in Surgical Pathology Program Objectives, Goals, and Supervision of Fellows in Surgical Pathology Page 11 - 1 SECTION 11: PROGRAM OBJECTIVES, GOALS, AND SUPERVISION OF FELLOWS IN SURGICAL PATHOLOGY Overview Mission The mission statement of our anatomic pathology training program is to train Statement outstanding subspecialty pathologists and to provide them with the necessary tools and experience to pursue a scientific approach to the practice of anatomic pathology that will not only enhance their professional lives but will also advance the field of Surgical Pathology as a whole. The Surgical Pathology Fellowship has continued accreditation by the ACGME. Policies The fellows in Surgical Pathology are subject to the same Policies as applies to the residents in the general pathology residents discussed in Section 1. Specific policies on Duty Hours, Stress and Fatigue and Moonlighting follow. Duty Hours The fellows in Surgical Pathology cover After Hours (evening and weekend call) Intraoperative Consultation and Frozen Section call. As such, the fellows in Surgical Pathology must comply with the ACGME Duty Hours. o Surgical Pathology Fellows do not take in-house call. As such, the limit to on- call every third day does not apply. o Fellows cover call from 4:30 p.m. to 7:30 a.m. the next business day. Evening and weekend call is taken for a weeklong duration. o Fellows must not take call more than twice in a 28 day period of time, in order to have one day free of all hospital duties (day and evening, pager off) in seven days, averaged over 28 days.
    [Show full text]
  • Download (8MB)
    THE VALUE OF IMMUNOFLUORESCENCE IN RENAL DISEASES WITH SPECIAL REFERENCE TO PERIODIC ACID SCHIFF AND JONE’S METHANAMINE SILVER STAIN Dissertation submitted in Partial fulfillment of the regulations required for the award of M.D. DEGREE In PATHOLOGY – BRANCH III THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY CHENNAI APRIL 2015 DECLARATION I hereby declare that the dissertation entitled THE VALUE OF IMMUNOFLUORESCENCE IN RENAL DISEASES WITH SPECIAL REFERENCE TO PERIODIC ACID SCHIFF AND JONE’S METHANAMINE SILVER STAIN is a bonafide research work done by me in the Department of Pathology, Coimbatore Medical College, Coimbatore during the period from October 2012 to July 2014 under the guidance and supervision of Dr. D. Kavitha M.D ., Associate Professor, Department of Pathology, Coimbatore Medical College, Coimbatore. This dissertation is submitted to the Tamilnadu Dr.M.G.R. Medical University, Chennai towards the partial fulfilment of the requirement for the award of M.D., Degree (Branch III) in Pathology. I have not submitted this dissertation on any previous occasion to any University for the award of any Degree. Place: Coimbatore Date: Dr. C.S. AKSHATHA CERTIFICATE This is to certify that dissertation entitled THE VALUE OF IMMUNOFLUORESCENCE IN RENAL DISEASES WITH SPECIAL REFERENCE TO PERIODIC ACID SCHIFF AND JONE’S METHANAMINE SILVER STAIN is a bonafide work done by Dr. C.S . Akshatha, a postgraduate student in the Department of Pathology, Coimbatore Medical College and Hospital, Coimbatore under the supervision and guidance of Dr. D. Kavitha M.D., Associate Professor, Department of Pathology, Coimbatore Medical College and Hospital, Coimbatore in partial fulfilment of the regulations of the Tamilnadu Dr.
    [Show full text]
  • Index Medicus for the Eastern Mediterranean Region (IMEMR) Monazamet El Seha El Alamia Street Extension of Abdel Razak El Sanhouri Street P.O
    ISSN: 2071-2510 Vol. 11 No.2 For further information contact: World Health Organization Regional Office for the Eastern Mediterranean Knowledge Sharing and Production (KSP) Index Medicus for the Eastern Mediterranean Region (IMEMR) Monazamet El Seha El Alamia Street Extension of Abdel Razak El Sanhouri Street P.O. Box 7608, Nasr City Cairo 11371, Egypt Tel: +20 2 22765047 IMEMR Current Contents Fax: +20 2 22765424 December 2017 e-mail: [email protected] Vol. 16 No. 4 Providing Access to Health Knowledge to Build a Healthy Future http://www.emro.who.int/information-resources/imemr/imemr.html Index Medicus for the WHO Eastern Mediterranean Region with Abstracts IMEMR Current Contents December 2017 Vol. 16 No. 4 © World Health Organization 2017 All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate borderlines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication.
    [Show full text]
  • RENAL PATHOLOGY Richard Sibley, MD • Megan Troxell, MD
    Neeraja Kambham, MD • John Higgins, MD RENAL PATHOLOGY Richard Sibley, MD • Megan Troxell, MD 300 Pasteur Drive, Room H2112 Pathologist On Call Cell Phone: (650)391-5338 BILL TO: Stanford, CA 94305-5243 EM Lab: (650) 725-5196 Fax: (650) 725-7409 URL: http://renalpathology.stanford.edu Patient PPO HMO* Client Medicare Outpatient Patient Name (Last) (First) DOB HMO Insurance Authorization # Inpatient *Referring facility is responsible for obtaining HMO authorization. If claim is denied due for lack of authorization, the referring facility will be billed for services Referring Institution MRN Sex Patient’s Phone Number Insurance Info: Attach a copy of front & back of Insurance card or face sheet. Technical (lab) and professional (M.D.) charges are billed separately. M F ( ) Patient Address City State Zip Code Referring Institution/Nephrology Practice For Lab Use Only Ordering Physician Name:_______________________________________ Date: _____________ NPI#: ______________________ Phone: ___________________________ Nephrologist (if not Ordering Physician) Name:__________________________________________ Signature - REQUIRED: ________________________________ Phone: ___________________ COPIES Name, Fax, Address TO: Patient History: Family History: Renal Disease Known Duration: Hypertension Diabetes □ Native Kidney Height Weight □ARF □CKD □Yes □ No BP: □Yes □ No □ Transplant Kidney Specimen Information: Relevant Drugs: # of Cores Core Length (cm) Formalin (Light): | | Antibiotics: □Yes □ No Drug Name: # of Cores Core Length (cm) Zeus (IF): | |
    [Show full text]
  • The Division of Renal Diseases and Hypertension Fellowship Program
    The Division of Renal Diseases and Hypertension Fellowship Program in Nephrology Kevin Finkel, MD, FACP, FASN, FCCM Program Director Professor and Executive Vice-Chairman of Medicine Director, Division of Renal Diseases and Hypertension Dia Waguespack, MD, FASN Associate Program Director Assistant Professor Division of Renal Diseases and Hypertension he primary goal of the Nephrology Fellowship Program at The University of Texas Medical School at Houston is to prepare accomplished subspecialists T in nephrology with a specific emphasis on training of the academic nephrologist. The fellowship program is a two year program with four to five positions per year. The program is fully accredited by the Accreditation Council for Graduate Medical Education and meets the requirements for certification in Nephrology by the American Board of Internal Medicine. Trainees acquire the knowledge and procedural skills necessary to deliver superb care to patients with a wide array of kidney disorders and hypertension. They also receive training in the design, conduct and analysis of clinical or basic research from a group of prominent renal investigators. The Program is located in the prestigious Texas Medical Center in downtown Houston. One of the largest medical facilities of its kind in the world, the Texas Medical Center consists of fifty-four academic/research institutes and hospitals, providing unsurpassed opportunities for clinical and research training. Because of its reputation and unique features as a patient care, biomedical research and education “city,” the Texas Medical Center has also attracted an impressive list of residents and visiting scientists with which trainees can interact and study. Given the proximity of the various institutions on campus, attendance at conferences or informal discussions at other institutions is extremely easy.
    [Show full text]
  • EAU Guidelines on Renal Transplantation
    EAU Guidelines on Renal Transplantation A. Breda (Chair), K. Budde, A. Figueiredo, E. Lledó García, J. Olsburgh (Vice-chair), H. Regele Guidelines Associates: R. Boissier, C. Fraser Taylor, V. Hevia, O. Rodríguez Faba, R.H. Zakri © European Association of Urology 2020 TABLE OF CONTENTS PAGE 1. INTRODUCTION 4 1.1 Aim and objectives 4 1.2 Panel Composition 4 1.3 Available publications 4 1.4 Publication history 4 2. METHODS 4 2.1 Introduction 4 2.2 Review and future goals 5 3. THE GUIDELINE 5 3.1 Organ retrieval and transplantation surgery 5 3.1.1 Living-donor nephrectomy 5 3.1.2 Organ preservation 6 3.1.2.1 Kidney storage solutions and cold storage 6 3.1.2.2 Duration of organ preservation 7 3.1.2.3 Methods of kidney preservation: static and dynamic preservation 7 3.1.3 Donor Kidney biopsies 8 3.1.3.1 Procurement Biopsies 9 3.1.3.1.1 Background and prognostic value 9 3.1.3.2 Type and size of biopsy 9 3.1.3.3 Summary of evidence and recommendations 10 3.1.3.4 Implantation biopsies 10 3.1.4 Living and deceased donor implantation surgery 10 3.1.4.1 Anaesthetic and peri-operative aspects 10 3.1.4.2 Immediate pre-op haemodialysis 10 3.1.4.3 Operating on patients taking anti-platelet and anti-coagulation agents 11 3.1.4.4 What measures should be taken to prevent venous thrombosis including deep vein thrombosis during and after renal transplant? 11 3.1.4.5 Is there a role for peri-operative antibiotics in renal transplantation? 12 3.1.4.6 Is there a role for specific fluid regimes during renal transplantation and central venous pressure measurement
    [Show full text]
  • Medical Renal Pathology (Including Transplantation)
    LABORATORY INVESTIGATION THE BASIC AND TRANSLATIONAL PATHOLOGY RESEARCH JOURNAL LI VOLUME 99 | SUPPLEMENT 1 | MARCH 2019 2019 ABSTRACTS MEDICAL RENAL PATHOLOGY (INCLUDING TRANSPLANTATION) (1581-1620) MARCH 16-21, 2019 PLATF OR M & 2 01 9 ABSTRACTS P OSTER PRESENTATI ONS EDUCATI ON C O M MITTEE Jason L. Hornick , C h air Ja mes R. Cook R h o n d a K. Y a nti s s, Chair, Abstract Revie w Board S ar a h M. Dr y and Assign ment Co m mittee Willi a m C. F a q ui n Laura W. La mps , Chair, C ME Subco m mittee C ar ol F. F ar v er St e v e n D. Billi n g s , Interactive Microscopy Subco m mittee Y uri F e d ori w Shree G. Shar ma , Infor matics Subco m mittee Meera R. Ha meed R aj a R. S e et h al a , Short Course Coordinator Mi c h ell e S. Hir s c h Il a n W ei nr e b , Subco m mittee for Unique Live Course Offerings Laksh mi Priya Kunju D a vi d B. K a mi n s k y ( Ex- Of ici o) A n n a M ari e M ulli g a n Aleodor ( Doru) Andea Ri s h P ai Zubair Baloch Vi nita Parkas h Olca Bast urk A nil P ar w a ni Gregory R. Bean , Pat h ol o gist-i n- Trai ni n g D e e p a P atil D a ni el J.
    [Show full text]
  • Resident and Medical Student Forum
    Medical Student Clinical Vignette New York Chapter ACP Resident and Medical Student Forum Saturday, November 9, 2013 University of Rochester School of Medicine and Dentistry 415 Elmwood Avenue Rochester, NY 14643 Medical Student Clinical Vignette New York Chapter ACP Resident and Medical Student Forum Medical Student Clinical Vignette 1 Medical Student Clinical Vignette Author: Brett Grobman Author: David Haughey Additional Authors: Daniel Jipescu Additional Authors: Bhardwaj, Rahul MD, Narsipur, Sri MD. Craig Grobman, D.O. Institution: SUNY Upstate Medical School Institution: St. Francis Hospital Title: PRES After Renal Transplantation: A Simple Solution Title: MULTIPLE MYELOMA PRESENTING AS CVA for a Complicated Patient SECONDARY TO MARANTIC ENDOCARDITIS Posterior reversible leukoencephalopathy syndrome (PRES) is characterized by acute neurologic dysfunction coupled with Learning objective: Recognize the importance of completely characteristic findings on brain imaging. PRES occurs in working up CVA. hypertensive emergency, eclampsia and as a neurotoxic effect Case: A 63-year-old male patient with a history of diabetes, of immunosuppressive agents. While overwhelmingly hyperlipidemia and coronary artery disease presented to ER reversible without residual deficits when promptly with right-sided weakness and aphasia. On MRI several acute recognized, vague symptomatology may delay diagnosis. focal infarctions within portions of the left cerebral A 50 year-old male was air-lifted to this institution due to hemisphere were noted. Suspecting cardioembolic event, a multiple episodes of seizure. He had undergone cadaveric transesophageal echocardiography (TEE) was performed. An renal transplant five days prior for end-stage renal disease aortic valve vegetation was found, which was thought to have secondary to focal segmental glomerulosclerosis. He did not most likely led to his thromboembolic event.
    [Show full text]
  • EAU Guidelines on Renal Transplantation 2018
    EAU Guidelines on Renal Transplantation A. Breda (Chair), K. Budde, A. Figueiredo, E. Lledó García, J. Olsburgh (Vice-chair), H. Regele Guidelines Associates: R. Boissier, C. Fraser Taylor, V. Hevia, O. Rodríguez Faba, R.H. Zakri © European Association of Urology 2018 TABLE OF CONTENTS PAGE 1. INTRODUCTION 4 1.1 Aim and objectives 4 1.2 Panel Composition 4 1.3 Available publications 4 1.4 Publication history 4 2. METHODS 4 2.1 Introduction 4 2.2 Review and future goals 5 3. THE GUIDELINE 5 3.1 Organ retrieval and transplantation surgery 5 3.1.1 Living-donor nephrectomy 5 3.1.2 Organ preservation 6 3.1.2.1 Kidney storage solutions and cold storage 6 3.1.2.2 Duration of organ preservation 7 3.1.2.3 Methods of kidney preservation: static and dynamic preservation 7 3.1.3 Donor Kidney biopsies 8 3.1.3.1 Procurement Biopsies 9 3.1.3.1.1 Background and prognostic value 9 3.1.3.2 Type and size of biopsy 9 3.1.3.3 Summary of evidence and recommendations 10 3.1.3.4 Implantation biopsies 10 3.1.4 Living and deceased donor implantation surgery 10 3.1.4.1 Anaesthetic and peri-operative aspects 10 3.1.4.2 Immediate pre-op haemodialysis 11 3.1.4.3 Operating on patients taking anti-platelet and anti-coagulation agents 11 3.1.4.4 What measures should be taken to prevent venous thrombosis including deep vein thrombosis during and after renal transplant? 11 3.1.4.5 Is there a role for peri-operative antibiotics in renal transplant? 12 3.1.4.6 Is there a role for specific fluid regimes during renal transplantation and central venous pressure measurement
    [Show full text]